Archive: October 2017
Hepatitis C
Noninvasive Assessment of Fibrosis Regression in Hepatitis C Virus Sustained Virologic Responders
Hirsh D. Trivedi, MD, Steven C. Lin, MD, and Daryl T. Y. Lau, MD, MSc, MPH
Abstract: The emergence of direct-acting antiviral (DAA) therapies and noninvasive measures of liver fibrosis has streamlined the management of patients with chronic hepatitis C virus […]
Short Bowel Syndrome
Managing the Adult Patient With Short Bowel Syndrome
Carol Rees Parrish, MS, RD, and John K. DiBaise, MD
Abstract: Short bowel syndrome (SBS) is a malabsorptive disorder associated with significant morbidity and mortality, reduced quality of life, and high health care costs. Managing […]
Hepatology
The Use of Nonselective Beta Blockers for Treatment of Portal Hypertension
Guadalupe Garcia-Tsao, MD
G&H What are the various stages of portal hypertension? GG-T Portal hypertension, which simply refers to an increase in portal pressure, can occur in different […]
IBD
Introduction to Biosimilar Use in Patients With Inflammatory Bowel Disease
Gary R. Lichtenstein, MD
G&H What is a biosimilar? GL According to the US Food and Drug Administration (FDA), a biosimilar is a product that is highly similar to […]
Endoscopy
The Past, Present, and Future of Endoscopic Retrograde Cholangiopancreatography
Richard A. Kozarek, MD
G&H How has endoscopic retrograde cholangiopancreatography evolved since its development? RK Endoscopic retrograde cholangiopancreatography (ERCP) was initially developed in 1968 as a diagnostic tool. Patients would […]
GERD
Hybrid Argon Plasma Coagulation in Patients With Barrett Esophagus
Oliver Pech, MD
G&H What are the most common risk factors for Barrett esophagus? OP The most common risk factors for Barrett esophagus are chronic heartburn and gastroesophageal […]
HCC
Current Status of Sorafenib Use for Treatment of Hepatocellular Carcinoma
Hashem B. El-Serag, MD, MPH
G&H What is the current understanding of the mechanism of action of sorafenib? HE-S Sorafenib (Nexavar, Bayer) is an orally administered, molecularly targeted medication for […]
Letter From the Editor
Letter from the Editor: Fall Conferences
Gary R. Lichtenstein, MD, AGAF, FACP, FACG
The fall conference season is upon us, with the World Congress of Gastroenterology at ACG2017 being held October 13 to 18 in Orlando, Florida, and The […]
Gastro-Hep News
Gastro-Hep News
Samantha Alleman
US Food and Drug Administration Clears Duodenoscope With Disposable Distal Cap On September 20, 2017, the US Food and Drug Administration (FDA) cleared the first duodenoscope […]